My view on current and future use of JAK inhibitors for ET, PV, and MF - 100004

Spotlight
Video

My view on current and future use of JAK inhibitors for ET, PV, and MF

imedex has 1231 videos Subscribe Here

Loading........
Description: In this presentation from the 2017 European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, Dr. Martin Griesshammer outlines his view on the current and future use of JAK inhibitors for essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF).

Earn CME Credit for a related activity: http://elc.imedex.com/ELC/S...

© 2017 Imedex, LLC.
Shared By : imedex
Posted on : 10/19/17
Added : 11 months ago